Postoperative Pain Pipeline Drugs Analysis Report, 2023: Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | Companies - Novartis, Allay Therapeutics, Antibe Therapeutics, Pharmaleads, Flexion Therapeutics, SiteOne T

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Postoperative Pain pipeline constitutes 7+ key companies continuously working towards developing 8+ Postoperative Pain treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Postoperative Pain Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Postoperative Pain Market.

The Postoperative Pain Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Postoperative Pain Pipeline Report: https://www.delveinsight.com/report-store/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Postoperative Pain treatment therapies with a considerable amount of success over the years. Postoperative Pain Key players such as - Allay Therapeutics, Antibe Therapeutics, Pharmaleads, Flexion Therapeutics, RHNanopharma, SiteOne Therapeutics, LipoCure, Nevakar, Jiangsu Hengrui Medicine, Novartis, Cytogel Pharma, Farmaceutica S.A., Vivozon, Sichuan Haisco Pharmaceutical, Ortho-McNeil Janssen Scientific Affairs, LLC, and others, are developing therapies for the Postoperative Pain treatment
• Postoperative Pain Emerging therapies such as - ATX-201, ATB-352, PL37, FX301, RHN-002, ST-2427, LC-400, NVK009, HR-021618, SAF312, CYT-1010, APSCTC, VVZ-149, HSK 21542, Tapentadol IR, and others are expected to have a significant impact on the Postoperative Pain market in the coming years.
• In June 2021, Formosa Pharmaceuticals and China Grand Pharma announced that they have entered into an exclusive licensing agreement for the development and commercialization of Formosa's APP13007 in the territory defined by Mainland China, Hong Kong, and Macau. APP13007, derived from Formosa's proprietary nanoparticle formulation platform, is a novel ophthalmic application of one of the most potent known corticosteroids for the treatment of inflammation and pain after cataract surgery
• In October 2021, Neumentum entered into a license agreement with Nuance Biotech Co. Ltd, a China based specialty pharmaceutical company, providing Nuance with the exclusive rights to develop and commercialize Neumentum's novel ktorolac for IV infusion (NTM-001) in China.
• In January 2021, IACTA Pharmaceuticals, Inc. and Pharmaleads announced they that have entered into licensing agreements, with IACTA acquiring global rights to Pharmaleads' Dual Enkephalinase Inhibitors (DENKI®), a novel class of non-opioid compounds for the treatment of acute and chronic ocular pain

Postoperative Pain Overview
Postoperative pain is an anticipated and temporary pain that occurs following grafting procedures or burn excision. Postoperative pain is experienced by the vast majority of patients who undergo surgical procedures

Get a Free Sample PDF Report to know more about Postoperative Pain Pipeline Therapeutic Assessment- https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Postoperative Pain Drugs Under Different Phases of Clinical Development Include:
• ATX-201: Allay Therapeutics
• ATB-352: Antibe Therapeutics
• PL37: Pharmaleads
• FX301: Flexion Therapeutics
• RHN-002: RHNanopharma
• ST-2427: SiteOne Therapeutics
• LC-400: LipoCure
• NVK009: Nevakar
• HR-021618: Jiangsu Hengrui Medicine
• SAF312: Novartis
• CYT-1010: Cytogel Pharma
• APSCTC: Farmaceutica S.A.
• VVZ-149: Vivozon
• HSK 21542: Sichuan Haisco Pharmaceutical

Route of Administration
Postoperative Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical
• Molecule Type

Molecule Type
Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
• Product Type

Postoperative Pain Pipeline Therapeutics Assessment
• Postoperative Pain Assessment by Product Type
• Postoperative Pain By Stage and Product Type
• Postoperative Pain Assessment by Route of Administration
• Postoperative Pain By Stage and Route of Administration
• Postoperative Pain Assessment by Molecule Type
• Postoperative Pain by Stage and Molecule Type

DelveInsight's Postoperative Pain Report covers around 5+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Postoperative Pain product details are provided in the report. Download the Postoperative Pain pipeline report to learn more about the emerging Postoperative Pain therapies at:
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Postoperative Pain Therapeutics Market include:
Key companies developing therapies for Postoperative Pain are - Menarini Group, Guidotti Farma, AcelRx Pharmaceuticals, Trevena, Inc., Heron Therapeutics, Innocoll Pharmaceuticals, DURECT Corporation, Pacira Pharmaceuticals, Baudax Bio, Bausch & Lomb, Ocular Therapeutix, Kala Pharmaceuticals, Inc, Medical Developments International Ltd (MVP), Hyloris Pharmaceuticals, AFT Pharmaceuticals, Cara Therapeutics, Vivozon, Avenue Therapeutics, Arthritis Innovation Corporation, MedinCell, Unither Pharmaceuticals, Esteve Pharmaceuticals, Formosa Pharmaceuticals, Neumentum Pharmaceuticals, Acadia Pharmaceuticals Inc., Nevakar, Inc., Taiwan Liposome Company (TLC), Viatris Inc. (formerly known as Mylan Inc.), Teikoku Pharma USA, Inc., Novartis Pharmaceuticals, Oculis, PainReform LTD, Concentric Analgesics, Mati Therapeutics Inc., and others.

Postoperative Pain Pipeline Analysis:
The Postoperative Pain pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Postoperative Pain with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Postoperative Pain Treatment.
• Postoperative Pain key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Postoperative Pain Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Postoperative Pain market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Postoperative Pain drugs and therapies- https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Postoperative Pain Pipeline Market Drivers
Rise in the number of surgical procedures worldwide, innovations in pain management, drug discovery and development, and government's initiative to promote better postoperative pain treatment are some of the important factors that are fueling the Postoperative Pain Market.

Postoperative Pain Pipeline Market Barriers
However, adverse effects associated with the medications, research Gaps in Practice Guidelines for Acute Postoperative Pain Management, and Age-specific Treatment and other factors are creating obstacles in the Postoperative Pain Market growth.

Scope of Postoperative Pain Pipeline Drug Insight
• Coverage: Global
• Key Postoperative Pain Companies: Allay Therapeutics, Antibe Therapeutics, Pharmaleads, Flexion Therapeutics, RHNanopharma, SiteOne Therapeutics, LipoCure, Nevakar, Jiangsu Hengrui Medicine, Novartis, Cytogel Pharma, Farmaceutica S.A., Vivozon, Sichuan Haisco Pharmaceutical, Ortho-McNeil Janssen Scientific Affairs, LLC, and others
• Key Postoperative Pain Therapies: ATX-201, ATB-352, PL37, FX301, RHN-002, ST-2427, LC-400, NVK009, HR-021618, SAF312, CYT-1010, APSCTC, VVZ-149, HSK 21542, Tapentadol IR, and others
• Postoperative Pain Therapeutic Assessment: Postoperative Pain current marketed and Postoperative Pain emerging therapies
• Postoperative Pain Market Dynamics: Postoperative Pain market drivers and Postoperative Pain market barriers

Request for Sample PDF Report for Postoperative Pain Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Postoperative Pain Report Introduction
2 Postoperative Pain Executive Summary
3 Postoperative Pain Overview
4 Postoperative Pain- Analytical Perspective In-depth Commercial Assessment
5 Postoperative Pain Pipeline Therapeutics
6 Postoperative Pain Late Stage Products (Phase II/III)
7 Postoperative Pain Mid Stage Products (Phase II)
8 Postoperative Pain Early Stage Products (Phase I)
9 Postoperative Pain Preclinical Stage Products
10 Postoperative Pain Therapeutics Assessment
11 Postoperative Pain Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Postoperative Pain Key Companies
14 Postoperative Pain Key Products
15 Postoperative Pain Unmet Needs
16 Postoperative Pain Market Drivers and Barriers
17 Postoperative Pain Future Perspectives and Conclusion
18 Postoperative Pain Analyst Views
19 Appendix
20 About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Related Reports:

Postoperative Pain Market https://www.delveinsight.com/report-store/postoperative-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Postoperative Pain-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Postoperative Pain Epidemiology https://www.delveinsight.com/report-store/postoperative-pain-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Postoperative Pain Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Scedosporium Infection Market https://www.delveinsight.com/report-store/scedosporium-infection-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Scedosporium Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Scedosporium Infection, historical and forecasted epidemiology as well as the Scedosporium Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Vascular Graft Devices Market https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2027 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Vascular Stents Market https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2027 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Bladder Scanners Market https://www.delveinsight.com/report-store/bladder-scanners-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Recent Blog's By DelveInsight:

• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Contact Us:

Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.